ObjectiveWe aimed to explore whether frailty was associated with fracture risk and whether frailty could modify the propensity of type 2 diabetes toward increased risk of fractures.Research design and methodsData were from a prospective cohort study. Our primary outcome was time to the first incident clinical fragility fracture; secondary outcomes included time to hip fracture and to clinical spine fracture. Frailty status was measured by a Frailty Index (FI) of deficit accumulation. The Cox model incorporating an interaction term (frailty × diabetes) was used for analyses.ResultsThe analysis included 3,149 (70% women) participants; 138 (60% women) had diabetes. Higher bone mineral density and FI were observed in participants with diabetes compared with control subjects. A significant relationship between the FI and the risk of incident fragility fractures was found, with a hazard ratio (HR) of 1.02 (95% CI 1.01-1.03) and 1.19 (95% CI 1.10-1.33) for per-0.01 and per-0.10 FI increase, respectively. The interaction was also statistically significant (P = 0.018). The HR for per-0.1 increase in the FI was 1.33 for participants with diabetes and 1.19 for those without diabetes if combining the estimate for the FI itself with the estimate from the interaction term. No evidence of interaction between frailty and diabetes was found for risk of hip and clinical spine fractures.ConclusionsParticipants with type 2 diabetes were significantly frailer than individuals without diabetes. Frailty increases the risk of fragility fracture and enhances the effect of diabetes on fragility fractures. Particular attention should be paid to diabetes as a risk factor for fragility fractures in those who are frail.
frailty type 2 diabetes fracture, bone health diabetes mellitus, frailty index fracture risk, diabetes bone density fragility fractures, hip fracture diabetes frailty, osteoporosis type 2 diabetes, frailty assessment diabetes complications, diabetes bone metabolism
Cite this article
Li, G., Prior, J. C., Leslie, W. D., Thabane, L., Papaioannou, A., Josse, R. G., Kaiser, S. M., Kovacs, C. S., Anastassiades, T., Towheed, T., Davison, K. S., Levine, M., Goltzman, D., Adachi, J. D., & CaMos Research Group (2019). Frailty and Risk of Fractures in Patients With Type 2 Diabetes. *Diabetes care*, *42*(4), 507-513. https://doi.org/10.2337/dc18-1965
Li G, Prior JC, Leslie WD, Thabane L, Papaioannou A, Josse RG, et al. Frailty and Risk of Fractures in Patients With Type 2 Diabetes. Diabetes Care. 2019;42(4):507-513. doi:10.2337/dc18-1965
Li, G., et al. "Frailty and Risk of Fractures in Patients With Type 2 Diabetes." *Diabetes care*, vol. 42, no. 4, 2019, pp. 507-513.
Twenty-eight patients with type I diabetes mellitus, legally blind as a result of proliferative retinopathy, were recruited into a program designed to teach and evaluate tactile methods for self-monit...
It is recognized that the trabecular bone score (TBS) provides skeletal information, and frailty measurement is significantly associated with increased risks of adverse health outcomes. Given the subo...
Naltrexone (NTX) is a non-selective antagonist of opioid receptors, primarily used in the therapy of opioid and alcohol dependence. Low-dose naltrexone (LDN) exhibits antagonistic action against the o...
Objective: Fetal Lower Urinary Tract Obstruction (LUTO) is associated with oligohydramnios and significant fetal morbidity, resulting in poor lung development and perinatal death. However, oligohydram...